FINISH LINE
Current medicinal chemistry , 31 (29), 4579-4601
MT received lecture fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sumitomo, and Mitsubishi Tanabe and received subsidies from Super Light Water, TAKAGI, Roche DC, and LifeScan
Dulaglutide (Trulicity) Exenatide (Byette) Exenatide extended-release (Bydureon) Liraglutide (Victoza) used for obesity Lixisenatide (Adlyxin) Semaglutide injection (Ozempic) used for obesity Semaglutide tablets (Rybelsus) used for obesity Tirzepatide (Mounjaro) a dual GLP-1/GIP receptor agonist If youre looking for how to lose weight without exercise and diet, GLP-1 agonist medications for type 2 diabetics and those with obesity might be something your doctor recommends to you
Similarly, AR variants that result from AR gene re-arrangements or alternative splicing under ADT lead to a novel AR cistrome that at least partially overlaps with that bound by full-length AR [62,63,64]